These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


128 related items for PubMed ID: 22190510

  • 1. Prognostic evaluation of CapG, gelsolin, P-gp, GSTP1, and Topo-II proteins in non-small cell lung cancer.
    Zhu WY, Hunag YY, Liu XG, He JY, Chen DD, Zeng F, Zhou JH, Zhang YK.
    Anat Rec (Hoboken); 2012 Feb; 295(2):208-14. PubMed ID: 22190510
    [Abstract] [Full Text] [Related]

  • 2. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H, Lu D, Shu Y, Shi W, Lu S, Wang K.
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [Abstract] [Full Text] [Related]

  • 3. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H, Lu D, Shu Y, Shi W, Lu S, Wang K.
    Hepatogastroenterology; 2008 May; 55(86-87):1530-6. PubMed ID: 19102336
    [Abstract] [Full Text] [Related]

  • 4. 99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis.
    Yüksel M, Cermik TF, Doğanay L, Karlikaya C, Cakir E, Salan A, Berkarda S.
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):876-81. PubMed ID: 12111127
    [Abstract] [Full Text] [Related]

  • 5. Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer.
    Dingemans AM, Witlox MA, Stallaert RA, van der Valk P, Postmus PE, Giaccone G.
    Clin Cancer Res; 1999 Aug; 5(8):2048-58. PubMed ID: 10473085
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer.
    Yang J, Ramnath N, Moysich KB, Asch HL, Swede H, Alrawi SJ, Huberman J, Geradts J, Brooks JS, Tan D.
    BMC Cancer; 2006 Aug 01; 6():203. PubMed ID: 16882345
    [Abstract] [Full Text] [Related]

  • 7. [Expression and significance of MRP, GST-pi, Topo IIalpha, and LRP in gastric carcinoma].
    Yu DQ, Yi YF.
    Ai Zheng; 2003 May 01; 22(5):496-9. PubMed ID: 12753710
    [Abstract] [Full Text] [Related]

  • 8. Placental isoform glutathione S-transferase and P-glycoprotein expression in advanced nonsmall cell lung cancer: association with response to treatment and survival.
    Vlachogeorgos GS, Manali ED, Blana E, Legaki S, Karagiannidis N, Polychronopoulos VS, Roussos C.
    Cancer; 2008 Dec 25; 114(6):519-26. PubMed ID: 19006072
    [Abstract] [Full Text] [Related]

  • 9. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer.
    Bria E, Visca P, Novelli F, Casini B, Diodoro MG, Perrone-Donnorso R, Botti C, Sperduti I, Facciolo F, Milella M, Cecere FL, Cognetti F, Mottolese M.
    Eur J Surg Oncol; 2008 May 25; 34(5):593-8. PubMed ID: 17693049
    [Abstract] [Full Text] [Related]

  • 10. [Multidrug resistance and its relationship with neuroendocrine differentiation in non-small cell lung carcinoma].
    Yu SP, Xiong YY, Tian SF.
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Mar 25; 26(3):165-8. PubMed ID: 12816683
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.
    Lung Cancer; 2008 Oct 25; 62(1):113-9. PubMed ID: 18550205
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of gelsolin expression level and variability in non-small cell lung cancer.
    Yang J, Tan D, Asch HL, Swede H, Bepler G, Geradts J, Moysich KB.
    Lung Cancer; 2004 Oct 25; 46(1):29-42. PubMed ID: 15364130
    [Abstract] [Full Text] [Related]

  • 13. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
    Woenckhaus M, Merk J, Stoehr R, Schaeper F, Gaumann A, Wiebe K, Hartmann A, Hofstaedter F, Dietmaier W.
    Hum Pathol; 2008 Jan 25; 39(1):126-36. PubMed ID: 17949785
    [Abstract] [Full Text] [Related]

  • 14. Expression of Y box-binding protein-1 correlates with DNA topoisomerase IIalpha and proliferating cell nuclear antigen expression in lung cancer.
    Gu C, Oyama T, Osaki T, Kohno K, Yasumoto K.
    Anticancer Res; 2001 Jan 25; 21(4A):2357-62. PubMed ID: 11724293
    [Abstract] [Full Text] [Related]

  • 15. [Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].
    Huang PY, Liang XM, Lin SX, Luo RZ, Hou JH, Zhang L.
    Ai Zheng; 2004 Jul 25; 23(7):845-50. PubMed ID: 15248926
    [Abstract] [Full Text] [Related]

  • 16. Expression status of ribonucleotide reductase small subunits hRRM2/p53R2 as prognostic biomarkers in stage I and II non-small cell lung cancer.
    Hsu NY, Wu JY, Liu X, Yen Y, Chen CY, Chou MC, Lin CH, Lee H, Cheng YW.
    Anticancer Res; 2011 Oct 25; 31(10):3475-81. PubMed ID: 21965764
    [Abstract] [Full Text] [Related]

  • 17. Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma.
    Lu C, Spitz MR, Zhao H, Dong Q, Truong M, Chang JY, Blumenschein GR, Hong WK, Wu X.
    Cancer; 2006 Jan 15; 106(2):441-7. PubMed ID: 16342067
    [Abstract] [Full Text] [Related]

  • 18. Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer.
    Lin X, Gu J, Lu C, Spitz MR, Wu X.
    Clin Cancer Res; 2006 Oct 01; 12(19):5720-5. PubMed ID: 17020976
    [Abstract] [Full Text] [Related]

  • 19. The role of survivin on overall survival of non-small cell lung cancer, a meta-analysis of published literatures.
    Fan J, Wang L, Jiang GN, He WX, Ding JA.
    Lung Cancer; 2008 Jul 01; 61(1):91-6. PubMed ID: 18192073
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.